Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center

This phase 2, single-center clinical trial evaluated the efficacy and safety of guadecitabine, with or without donor lymphocyte infusion, following allogeneic stem cell transplantation (allo-SCT) in adult patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The study had t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Betül Oran, Peter Thall, Amin Alousi, Gheath Al-Atrash, Rohtesh Mehta, David Marin, Partow Kebriaei, Uday Popat, Roland Bassett, Qaiser Bashir, Jin Im, Amanda Olson, Jessica Jewell, Portia Smallbone, Elizabeth Shpall, Richard Champlin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2025-07-01
coleção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/12186
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!